SEC Form 4 · accession 0001225208-18-002799
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Link Ph.D.
Director
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 9, 2018 | S | 3,600 | $122.6114 | D | 24,400 | I | * |
| Common StockF3,F2 | Feb 9, 2018 | S | 8,400 | $122.0836 | D | 16,000 | I | * |
| Common Stock | holding | — | — | — | 24,596 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $122.48 to $122.84. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2Held by the Link Family Trust, dated May 31, 1990, and the Link Family Enterprise, LLC.
- F3This transaction was executed in multiple trades at prices ranging from $121.47 to $122.46. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Power of Attorney is attached.